Oxford Immunotec

A medical diagnostics company, develops tests for various diseases.

Launch date

2001

Employees

Market cap

Enterprise valuation

Company register number 04516079

Milton England (HQ)

http://www.oxfordimmunotec.com/

https://twitter.com/oxfdimmunotec http://www.facebook.com/pages/Oxford-Immunotec/105616676142735 https://www.linkedin.com/company/oxford-immunotec

Revenues, earnings & profits over time

USD	2016	2017	2018	2019	2020	2021	2022
Revenues	-	54.0m	59.0m	73.0m	58.0m	82.0m	94.0m
% growth	-	-	9 %	24 %	(21 %)	41 %	15 %
EBITDA	11.0m	27.0m	16.0m	3.0m	(13.0m)	(3.0m)	(26.1m)
% EBITDA margin	-	50 %	27 %	4 %	(22 %)	(4 %)	(28 %)
Profit	4.4m	32.0m	121m	1.0m	(15.0m)	(2.0m)	2.0m
% profit margin	-	59 %	205 %	1 %	(26 %)	(2 %)	2 %

Date	Investors	Amount	Round
Jan 2001	University of Oxford	N/A	Spinout
Nov 2003	Questor Capital	£2.5m	Series A
Aug 2005	Prelude Trust Dow	£7.0m	Series B
Oct 2007	Wellington Partners Prelude Trust Clarus Ventures Dow NTEC	$40.0m	Series C
May 2010	Molten Ventures Wellington Partners SPARK Ventures New Leaf Venture Partners Clarus Ventures Kaiser Permanente Ventures	$26.0m	Series D
Jun 2012	Molten Ventures Wellington Partners SPARK Ventures Imperial Innovations New Leaf Venture Partners Clarus Ventures Invesco Kaiser Permanente Ventures & 1 more	$28.0m	Late VC
Jan 2013*	N/A	$12.0m	Debt
Oct 2013	N/A	$64.3m	IPO
Jan 2015*	N/A	$53.7m	Post IPO Equity
Oct 2016	Midcap Financial	$40.0m	Post IPO Debt
Mar 2021	Perkinelmer Las (Uk) Limited	N/A	Acquisition
Total Funding		€96.9m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Oxford Immunotec Oct 2016

ACQUISITION by Oxford Immunotec Jun 2016